Cite
HARVARD Citation
Outterson, K. et al. (2022). Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010–2020. Clinical infectious diseases. pp. 1183-1190. [Online].